GCA
CDNA icon

Greenwood Capital Associates’s CareDx CDNA Stock Holding History

Greenwood Capital Associates’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,465
Closed -$222K – 234
2022
Q4 		$222K Sell
19,465
-11,164
-36% -$165K 0.04% 204
2022
Q3 		$521K Sell
30,629
-456
-1% -$9.79K 0.09% 173
2022
Q2 		$668K Buy
31,085
+2,377
+8% +$65.9K 0.11% 151
2022
Q1 		$1.06M Buy
28,708
+6,312
+28% +$246K 0.28% 72
2021
Q4 		$1.02M Buy
22,396
+2,565
+13% +$134K 0.14% 124
2021
Q3 		$1.26M Buy
19,831
+1,811
+10% +$138K 0.19% 95
2021
Q2 		$1.65M Buy
18,020
+69
+0.4% +$5.49K 0.25% 78
2021
Q1 		$1.22M Sell
17,951
-1,226
-6% -$95.2K 0.19% 92
2020
Q4 		$1.39M Buy
19,177
+1,491
+8% +$86.4K 0.23% 79
2020
Q3 		$671K Buy
17,686
+6,525
+58% +$220K 0.13% 101
2020
Q2 		$395K Buy
11,161
+224
+2% +$6.38K 0.09% 120
2020
Q1 		$239K Sell
10,937
-683
-6% -$15.3K 0.07% 127
2019
Q4 		$251K Buy
11,620
+2,470
+27% +$56.7K 0.05% 167
2019
Q3 		$207K Buy
+9,150
New +$253K 0.05% 161

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Greenwood Capital Associates's CDNA Position: Q1 2023 in Review

Greenwood Capital Associates sold out of CareDx (CDNA) in Q1 2023, closing a stake of 19,465 shares — an estimated $222K sold.

Greenwood Capital Associates first reported a position in CDNA in Q3 2019 and held it in 14 quarters. The position peaked at $1.65M in Q2 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Greenwood Capital Associates reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Greenwood Capital Associates sold 19,465 CareDx shares in Q1 2023, an estimated $222K.
  • Greenwood Capital Associates first reported a position in CareDx in Q3 2019 and held it in 14 quarters.
  • Greenwood Capital Associates's CareDx position peaked at $1.65M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Greenwood Capital Associates's 13F filing for Q1 2023, filed 12 May 2023.